R T Ncube1, K C Takarinda2,3, C Zishiri1, W van den Boogaard4, N Mlilo1, C Chiteve1, N Siziba3, F Trinchán5, C Sandy3. 1. International Union Against Tuberculosis and Lung Disease (The Union), Zimbabwe Country Office, Harare, Zimbabwe. 2. Centre for Operations Research, The Union, Paris, France. 3. AIDS and TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe. 4. Operational Research Unit, Médecins Sans Frontières, Luxembourg City, Luxembourg. 5. Bulawayo City Health Department, Bulawayo, Zimbabwe.
Abstract
Setting: A high tuberculosis (TB) incidence, resource-limited urban setting in Zimbabwe. Objectives: To compare treatment outcomes among people initiated on first-line anti-tuberculosis treatment in relation to age and other explanatory factors. Design: This was a retrospective record review of routine programme data. Results: Of 2209 patients included in the study, 133 (6%) were children (aged <10 years), 132 (6%) adolescents (10-19 years), 1782 (81%) adults (20-59 years) and 162 (7%) were aged ⩾60 years, defined as elderly. The highest proportion of smear-negative pulmonary TB cases was among the elderly (40%). Unfavourable outcomes, mainly deaths, increased proportionately with age, and were highest among the elderly (adjusted relative risk 3.8, 95%CI 1.3-10.7). Having previous TB, being human immunodeficiency virus positive and not on antiretroviral treatment or cotrimoxazole preventive therapy were associated with an increased risk of unfavourable outcomes. Conclusion: The elderly had the worst outcomes among all the age groups. This may be related to immunosuppressant comorbidities or other age-related diseases mis-classified as TB, as a significant proportion were smear-negative. Older persons need better adapted TB management and more sensitive diagnostic tools, such as Xpert® MTB/RIF.
Setting: A high tuberculosis (TB) incidence, resource-limited urban setting in Zimbabwe. Objectives: To compare treatment outcomes among people initiated on first-line anti-tuberculosis treatment in relation to age and other explanatory factors. Design: This was a retrospective record review of routine programme data. Results: Of 2209 patients included in the study, 133 (6%) were children (aged <10 years), 132 (6%) adolescents (10-19 years), 1782 (81%) adults (20-59 years) and 162 (7%) were aged ⩾60 years, defined as elderly. The highest proportion of smear-negative pulmonary TB cases was among the elderly (40%). Unfavourable outcomes, mainly deaths, increased proportionately with age, and were highest among the elderly (adjusted relative risk 3.8, 95%CI 1.3-10.7). Having previous TB, being human immunodeficiency virus positive and not on antiretroviral treatment or cotrimoxazole preventive therapy were associated with an increased risk of unfavourable outcomes. Conclusion: The elderly had the worst outcomes among all the age groups. This may be related to immunosuppressant comorbidities or other age-related diseases mis-classified as TB, as a significant proportion were smear-negative. Older persons need better adapted TB management and more sensitive diagnostic tools, such as Xpert® MTB/RIF.
Entities:
Keywords:
Bulawayo; SORT IT; elderly; operational research
Authors: S Patra; S Lukhmana; K Tayler Smith; A T Kannan; S Satyanarayana; D A Enarson; R K Nagar; M Marcel; T Reid Journal: Trans R Soc Trop Med Hyg Date: 2013-11-04 Impact factor: 2.184
Authors: L Aaron; D Saadoun; I Calatroni; O Launay; N Mémain; V Vincent; G Marchal; B Dupont; O Bouchaud; D Valeyre; O Lortholary Journal: Clin Microbiol Infect Date: 2004-05 Impact factor: 8.067
Authors: Mweete D Nglazi; Katharina Kranzer; Pearl Holele; Richard Kaplan; Daniella Mark; Heather Jaspan; Stephen D Lawn; Robin Wood; Linda-Gail Bekker Journal: BMC Infect Dis Date: 2012-01-25 Impact factor: 3.090
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi Journal: Cochrane Database Syst Rev Date: 2022-09-06
Authors: Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas Journal: Cochrane Database Syst Rev Date: 2020-08-27
Authors: Simon Mutembo; Jane N Mutanga; Kebby Musokotwane; Cuthbert Kanene; Kevin Dobbin; Xiaobai Yao; Changwei Li; Vincent C Marconi; Christopher C Whalen Journal: BMC Infect Dis Date: 2019-12-30 Impact factor: 3.090